Hedge Fund Stock Picks & Ticker Coverage
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Eagle Capital Management Ravenel B. Curry III | “Humana has significant scale advantages in a consolidated industry that outgrows the overall economy. The industry moves with its own cycle and, over the last several years, has faced cost/price pressures in Medicare Advantage and Medicaid. Some weaker firms are unprofitable. We believe conditions have bottomed out and that we are transitioning to a multi-year improvement in margins and earnings. Humana is making good strides, and we expect significantly improved Star ratings for the company later this year.” | NEUTRAL | Q2 2026 Aug 4, 2026 | View Pitch |
Diamond Hill Large Cap Strategy Austin Hawley | “Health care services and insurance company Humana is a new holding in 2Q26 and the second-largest Medicare Advantage insurer in the US. Shares outperformed in 2Q26 after the company delivered strong 1Q26 results and on better-than-expected Medicare rate increases announced in early April, which will be helpful for the industry in closing the gap between pricing and cost trends. Health care services and insurance company Humana is the second-largest Medicare Advantage insurer in the US. Margins have been squeezed in recent years from rising medical costs and lower government reimbursement; however, we believe margins will normalize upward over time as the company prices to reflect higher utilization and as government reimbursement rates improve. Relative to a more normal earnings base, we believe the valuation is very attractive.” | BULL | Q2 2026 Jul 17, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.